Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment ofHelicobacter pyloriInfection: Two Pilot Studies

Rifabutin-based High-dose Proton-pump Inhibitor and Amoxicillin Triple Regimen as the Rescue treatment forHelicobacter pylori

(2014) Hyun Chul Lim et al.   HELICOBACTER

Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective Study

(2013) Xiao Liang et al.   Clinical Gastroenterology and Hepatology

The Efficacy of Two-Week Quadruple First-Line Therapy with Bismuth, Lansoprazole, Amoxicillin, Clarithromycin onHelicobacter pyloriEradication: A Prospective Study

(2013) Bilal Ergül et al.   HELICOBACTER

Effect of Fluoroquinolone Resistance on 14-day Levofloxacin Triple and Triple Plus Bismuth Quadruple Therapy

(2013) Jingxian Liao et al.   HELICOBACTER

Helicobacter pylorieradication in Western Australia using novel quadruple therapy combinations

(2012) C. Y. Tay et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

Quadruple therapy with moxifloxacin and bismuth for first-line treatment ofHelicobacter pylori

(2012) Antonio Francesco Ciccaglione   WORLD JOURNAL OF GASTROENTEROLOGY

The Optimal First-Line Therapy ofHelicobacter pyloriInfection in Year 2012

(2012) Chao-Hung Kuo et al.   Gastroenterology Research and Practice

Review article: rifabutin in the treatment of refractory Helicobacter pylori infection

(2011) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Is Culture Necessary before First-line Treatment for Helicobacter pylori Infection?

(2011) Javier P. Gisbert   INTERNAL MEDICINE

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

(2011) Peter Malfertheiner et al.   LANCET

Helicobacter pylorieradication therapy

(2010) Hidekazu Suzuki et al.   Future Microbiology

One-Week Once-Daily Triple Therapy with Esomeprazole, Moxifloxacin, and Rifabutin for Eradication of Persistent Helicobacter pylori Resistant to Both Metronidazole and Clarithromycin

(2010) Stephan Miehlke et al.   HELICOBACTER

Is Antimicrobial Susceptibility Testing Necessary Before First-line Treatment for Helicobacter pylori Infection? -Meta-analysis of Randomized Controlled Trials-

(2010) Yuan Wenzhen et al.   INTERNAL MEDICINE

Geographic map and evolution of primaryHelicobacter pyloriresistance to antibacterial agents

(2009) Lyudmila Boyanova et al.   Expert Review of Anti-Infective Therapy

Editorial: H. pylori Treatment: New Wine in Old Bottles?

(2008) Nimish Vakil   AMERICAN JOURNAL OF GASTROENTEROLOGY

Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis

(2008) Alexander C Ford et al.   WORLD JOURNAL OF GASTROENTEROLOGY